@article{article, title  = {{Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial}},

 url = {{}},

 year = {{2017}},

 month = {{6}},

 author = {{Earl HM and Hiller L and Howard HC and Dunn JA and Young J and Bowden SJ and McDermaid M and Waterhouse AK and Wilson G and Agrawal R and O'Reilly S et al}},

 doi = {{10.1016/S1470-2045(17)30319-4}},

 volume = {{18}},

 journal = {{The Lancet Oncology}},

 issue = {{6}},

 pages = {{755-769}},

 note = {{Accessed on 2025/10/10}}}